Delivery Order SPE2DB20D7059-SPE2DB24FQMU3

Award Date 9/13/24
Potential Completion Date 9/16/24
Potential Value $2.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $6,301.49, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Lidocaine 5% Patch 30s, a medical product, and has an ultimate completion date of April 14, 2025. The contract is a Delivery Order, with a Firm Fixed Price pricing type. This award is not associated with a set-aside designation, indicating open competition....
This federal contract award, valued at $1,163.45, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Lidocaine 5% Patch 30s, a prescription medication. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and has an ultimate completion date of February 12, 2025. This award is not associated with a set-aside designation, indicating open...
This federal contract award, valued at $3,556.23, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Lidocaine 5% Patch 30s, a medical product, and has an ultimate completion date of April 2, 2025. The contract is a Delivery Order under a Firm Fixed Price pricing type. This award is associated with Amerisourcebergen's larger Indefinite Delivery Contract (IDC)...
This federal contract award, valued at $1,596.76, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Lidocaine 5% Patch 30s, a medical product used for pain management. The contract has a completion date of May 9, 2024, and is structured as a Firm Fixed Price Delivery Order. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a...
This federal contract award, valued at $4,664.64, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4566121260 - Lidocaine 5% Patch 30s, with a completion date of October 17, 2024. The award is a Delivery Order under a Firm Fixed Price contract type. This contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp...
This federal contract award, valued at $2,363.52, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Lidocaine 5% Patch 30S, a medical supply item, with a completion date of January 31, 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999...
This federal contract award, valued at $10,247.63, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Lidocaine 5% Patch 30s, a medical product used for pain management. The contract is a Firm Fixed Price Delivery Order with a period of performance ending on February 26, 2024. The contract was not designated with any set-aside...
This federal contract award, valued at $1,176.18, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4568249854 - Lidocaine 5% Patch 30s, a medical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of May 15, 2025. The contract is not set aside and is open to full and open competition....
This federal contract award, valued at $14,922.93, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Lidocaine 5% Patch 30S, a medical supply item, with a completion date of December 3, 2024. The contract is a Delivery Order, with a Firm Fixed Price pricing type. It is not designated as a Set-Aside contract. AmerisourceBergen holds a significant Indefinite...
This federal contract award, valued at $5,628.49, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Lidocaine 5% Patch 30s, a medical product used for pain management. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of December 23, 2024. The contract was not set aside for any specific business type. AmerisourceBergen holds a...
  • SPE2DB20D7059
    Indefinite Delivery Contract
  • SPE2DB20D7059-SPE2DB24FQMU3
    Delivery Order

This federal contract award, valued at $2,388.00, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Lidocaine 5% Patch 30s, a topical anesthetic medication. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of September 16, 2024. There is no set-aside designation for this contract. Amerisourcebergen Drug Corp has been awarded multiple Indefinite Delivery Contracts (IDCs) by the DLA and other federal agencies, such as the Department of Justice Federal Bureau of Investigation, to provide a wide range of pharmaceutical and medical supplies to support various government healthcare programs and facilities, including military treatment facilities and veterans' hospitals.

Generated 1/3/25, 9:18 AM